Author

E. Salido

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Agraz-Doblas· 1 shared A. Astudillo· 1 shared A. L. Pey· 1 shared B. Casar· 1 shared B. Monterde· 1 shared C. de Medeiros Vieira· 1 shared C. L. Miller· 1 shared C. Morales Torres· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Agraz-Doblas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The 9p21.3 coronary artery disease risk locus drives vascular smooth muscle cells to an osteochondrogenic state

E. Salido, C. de Medeiros Vieira, J. Verdezoto Mosquera, R. Zade, P. Parikh, S. Suryavanshi, C. L. Miller, V. Lo Sardo

This study shows that the 9p21.3 CAD risk locus drives vascular smooth muscle cells to an osteochondrogenic state through ANRIL expression, leading to arterial calcification.

bioRxiv · May 25, 2024Cell Biology

Effect of naturally-occurring mutations on the stability and function of cancer-associated NQO1: comparison of experiments and computation.

J. L. Pacheco-Garcia, M. Cagiada, K. Tienne-Matos, E. Salido, K. Lindorff-Larsen, A. L. Pey

The paper compares computational predictions and experimental analysis of NQO1 variants to assess their stability and function, finding good correlation but noting outliers.

bioRxiv · Sep 30, 2022Biophysics

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to PARP inhibition in lung cancer

T. Moreno, L. Gonzalez-Silva, B. Monterde, I. Betancor-Fernandez, C. Revilla, A. Agraz-Doblas, J. Freire, P. Isidro, L. Quevedo, S. Montes-Moreno, L. Cereceda, A. Astudillo, B. Casar, P. Crespo, C. Morales Torres, , I. Varela

This study identifies ARID2 deficiency in 20% of lung cancer patients, showing it promotes tumor progression and increases sensitivity to PARP inhibition.

bioRxiv · Jan 10, 2020Cancer Biology